Patiromer and Sodium Zirconium Cyclosilicate in Treatment of Hyperkalemia: A Systematic Review and Meta-Analysis
ABSTRACT: Background: Patiromer and sodium zirconium cyclosilicate (SZC) are newer options for hyperkalemia treatment. This systematic review and meta-analysis were conducted to assess the safety and side effect profile of patiromer and SZC compared with placebo or other standards of care in the man...
Saved in:
Main Authors: | Dhan Bahadur Shrestha, MD Resident Physician (Author), Pravash Budhathoki, MD Resident Physician (Author), Yub Raj Sedhai, MD (Author), Ramkaji Baniya, MD (Author), Casey A. Cable, MD, MSc (Author), Markos G. Kashiouris, MD, MPH (Author), Dave L. Dixon, PharmD (Author), Jason M. Kidd, MD (Author), Yuvraj Adhikari, MBBS (Author), Anupama Marasini, MBBS (Author), Shakar Bhandari, MBBS (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Letter to the editor regarding ''Patiromer and Sodium Zirconium Cyclosilicate in Treatment of Hyperkalemia: A Systematic Review and Meta-analysis: Patiromer and Sodium Zirconium Cyclosilicate in Hyperkalemia'
by: Donna Zarzuela, PharmD, et al.
Published: (2021) -
Effects of Patiromer and Sodium Zirconium Cyclosilicate on Blood Pressure in Rats with Chronic Kidney Disease
by: Lingyun Li MD, PhD, et al.
Published: (2024) -
Cost-effectiveness analysis of sodium zirconium cyclosilicate for treating hyperkalemia among Chinese patients
by: Lei Tian, et al.
Published: (2023) -
Medical Costs in Patients with Hyperkalemia on Long-Term Sodium Zirconium Cyclosilicate Therapy: The RECOGNIZE II Study
by: Agiro A, et al.
Published: (2023) -
Prevalence, awareness, risk factors and control of hypertension in Nepal from 2000 to 2020: A systematic review and meta-analysis
by: Dhan Bahadur Shrestha, et al.
Published: (2021)